25.06.2024
Publications category: Oncology
25.06.2024
Model-informed early clinical development of BI-1808, a novel monoclonal antibody to tumor necrosis factor receptor 2
15.12.2023
Concentration-QTcF Analysis of Quizartinib in Patients With Newly Diagnosed (ND) Acute Myeloid Leukemia (AML)
15.12.2023
Population Pharmacokinetics (PopPK) of Quizartinib and Its Active Metabolite AC886 in Patients (Pts) With Newly Diagnosed (ND) Acute Myeloid Leukemia (AML)
01.11.2023
Rituximab PK and PD evaluation based on a study in diffuse large B-cell lymphoma: influence of tumor size on PK and assessment of PK similarity
01.11.2023
A framework for prediction of progression free survival based on modelling of sub-endpoints
23.08.2023
Model-informed drug development of autologous CAR-T cell therapy: Strategies to optimize CAR-T cell exposure leveraging cell kinetic/dynamic modeling
22.08.2023
Population PK analysis of Pegaspargase in Japanese and non-Japanese patients with acute lymphoblastic leukemia
22.08.2023
Application of tumor size modelling and simulations to support the dose selection of BI 907828 for a Phase II study
22.08.2023
Potential strategies to optimize CAR-T cell exposure in absence of dose-exposure relationships leveraging cell kinetic/dynamic models
14.06.2023